The Trump administration is getting pulled in opposite directions on its COVID-19 vaccine policy, sued by mainstream American medical associations for removing jab recommendations for healthy children and healthy pregnant women and pressured by jab opponents to further restrict the novel therapeutics, which continue to be mandated in some settings.
Now public health officials are faced with new evidence the jabs accelerate the cancer with the third-most deaths in the U.S and a five-year relative survival rate of 13.3%, which killed civil rights activist and Congressman John Lewis in 2020.
Researchers analyzing why pancreatic cancer survival rates at their Japanese hospital declined in 2022 and 2023, after years of steady increases, found a statistically significant connection between the number of mRNA doses taken by those patients and how quickly they died, even when considering “tumor, node, metastasis” (TNM) factors, surgery and chemotherapy.
Taking as little as the primary series and booster, which the Biden administration rushed through approval over the protests of its lead vaccine reviewers, is “associated with poorer overall survival in patients with PC,” the Miyagi Cancer Center researchers concluded in the peer-reviewed journal Cancers, published by Swiss open-access publisher MDPI.
Click this link for the original source of this article.
Author: Ray Hilbrich
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
